Capel Surgical Clinic & Vascular Center Saves Patients’ Limbs with Toshiba Medical’s Ultimax-i FPD

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

image 2017 6 Ultimax i XRVL

The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease which can result in the loss of a limb. To help minimize amputations among their patient population, Capel Surgical Clinic & Vascular Center in Greenwood, Miss., uses advanced X-ray technology to restore blood flow in occluded arteries. Capel Surgical Clinic also uses theUltimaxTM-i FPD multipurpose system from Toshiba Medical, a Canon Group company, for interventional procedures, diagnostic angiograms and aortagrams.

“The Ultimax-i FPD allows us to perform complex procedures, including angioplasty, stenting and atherectomy, which is a cost-effective, faster and minimally invasive endovascular treatment for removing atherosclerosis from arteries that can prevent amputation of a patient’s leg,” said Dr. Christopher Capel, vascular surgeon, Capel Surgical Clinic & Vascular Center. “We avoided hefty construction costs when installing the system because of its small footprint and it improved our competitive advantage and increased patient referrals while we expanded our services. Additionally, reducing radiation exposure was very important to us and we are confident that the Ultimax-i FPD’s dose management tools are making every exam safe and efficient.”

The Ultimax-i FPD multipurpose system expands the clinical capabilities of limited R&F room space with a compact tilting C-arm multipurpose system. It has a small footprint that installs adjacent to back walls to provide extended space for the operator. This improves patient access and allows for more complex procedures by providing routine angiography lab capabilities within an R&F room. Enabling clinicians to image, diagnose and treat a wide range of patients, the multipurpose system can accommodate up to 500 lbs. with a wide, high-capacity table to comfortably image patients. The system features full-spectrum detection on a flat panel detector with corner-to-corner, 43 cm x 43 cm coverage for high-resolution imaging.

“We understand the needs of healthcare providers like Capel Surgical Clinic & Vascular Center, and the Ultimax-i FPD has allowed them to expand patient care and simplify complex procedures,” said Satrajit Misra, vice president, Marketing and Strategic Development, Toshiba America Medical Systems, Inc. “By putting customers first, Toshiba Medical has designed the Ultimax-i FPD to offer healthcare providers the right technology for their specific patient population.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles